With increasing competition and consumer demand, pharmaceutical, biotech. and medical device manufacturers are becoming more patient focused. Almost overnight, organizations have made substantial changes in their approach to research, clinical trials, manufacturing, supply chain, cybersecurity, data privacy and patient engagements. Regulators across the world have started multiple initiatives to get lower-cost drugs and devices to market, and to streamline and accelerate the research and development process. To thrive in the new normal and to protect brand reputation, Life Sciences companies must adopt a comprehensive integrated risk management approach that brings together risk, compliance, audit, cybersecurity and business continuity programs enabling resilience and assurance to management, the board and regulators.GET MORE DETAILS
Layering in technology such as MetricStream allowed us to have transparency of information, all in one place and across all of our offices and…practices.
Chief Clinical Officer
Bayada Home Healthcare
We've got 2000 core users those are people that are in the solution at least annually. Of that 2000 number roughly 85% are in atleast quarterly.
Director, OGACC Technology and Operations
Better Decisions.REQUEST A DEMO
Strengthen risk and compliance to avoid the risk of violations, penalties and reputational damage.
90% reduction in the time taken to manage compliance activities.
67% Improvement in risk reporting visibility and efficiency for the executive management and board.
50% decrease in compliance issues.
50% compression in control testing timelines.